- Home
- EVRI vs MNKD Comparison
EVRI vs MNKD Comparison
Compare EVRI & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVRI
- MNKD
- Stock Information
- Founded
- EVRI 1998
- MNKD 1991
- Country
- EVRI United States
- MNKD United States
- Employees
- EVRI N/A
- MNKD N/A
- Industry
- EVRI Services-Misc. Amusement & Recreation
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- EVRI Consumer Discretionary
- MNKD Health Care
- Exchange
- EVRI Nasdaq
- MNKD Nasdaq
- Market Cap
- EVRI 1.2B
- MNKD 1.4B
- IPO Year
- EVRI 2005
- MNKD 2004
- Fundamental
- Price
- EVRI $14.05
- MNKD $4.58
- Analyst Decision
- EVRI Hold
- MNKD Buy
- Analyst Count
- EVRI 4
- MNKD 6
- Target Price
- EVRI $12.83
- MNKD $8.92
- AVG Volume (30 Days)
- EVRI 1.7M
- MNKD 1.6M
- Earning Date
- EVRI 05-20-2025
- MNKD 05-08-2025
- Dividend Yield
- EVRI N/A
- MNKD N/A
- EPS Growth
- EVRI N/A
- MNKD 215.86
- EPS
- EVRI 0.17
- MNKD 0.10
- Revenue
- EVRI $757,903,000.00
- MNKD $297,595,000.00
- Revenue This Year
- EVRI $1.83
- MNKD $14.23
- Revenue Next Year
- EVRI $3.48
- MNKD $14.56
- P/E Ratio
- EVRI $82.53
- MNKD $46.60
- Revenue Growth
- EVRI N/A
- MNKD 32.50
- 52 Week Low
- EVRI $6.37
- MNKD $4.17
- 52 Week High
- EVRI $14.06
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- EVRI 69.42
- MNKD 43.08
- Support Level
- EVRI $13.72
- MNKD $4.42
- Resistance Level
- EVRI $14.06
- MNKD $5.05
- Average True Range (ATR)
- EVRI 0.05
- MNKD 0.18
- MACD
- EVRI 0.01
- MNKD 0.01
- Stochastic Oscillator
- EVRI 95.31
- MNKD 36.74
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.